Predicting hydroxychloroquine clearance in healthy and diseased populations using a physiologically based pharmacokinetic approach

HIGHLIGHTS

• who: Faleh Alqahtani and colleagues from the Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia have published the article: Predicting Hydroxychloroquine Clearance in healthy and Diseased Populations Using a Physiologically Based Pharmacokinetic Approach, in the Journal: Pharmaceutics 2023, 15, 1250. of /2023/
• what: The PBPK models for HCQ have already been recently developed, in which one was focused on dose optimization of HCQ for specific populations in COVID-19 patients using concomitant medications , a second concentrated on determining the in_vitro anti-viral activity of HCQ and its optimization of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.